CIK: 0001802528 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $1,233,275 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 2,360,077 | $212,100 | 17.2% | $49.79 | +75.3% | COM | 05464T104 |
| NUVL | NUVALENT INC | 1,687,064 | $172,587 | 14.0% | $22.67 | +266.0% | COM | 670703107 |
| APGE | APOGEE THERAPEUTICS INC | 2,048,647 | $120,338 | 9.8% | $22.03 | +117.5% | COM | 03770N101 |
| SYRE | SPYRE THERAPEUTICS INC | 4,018,101 | $118,172 | 9.6% | $31.80 | -12.4% | COM NEW | 00773J202 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,202,798 | $81,799 | 6.6% | $18.66 | +24.1% | COM | 29337E102 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 3,204,841 | $80,089 | 6.5% | $18.73 | +30.0% | ORD SHS CL A | G52694109 |
| ORKA | ORUKA THERAPEUTICS INC | 3,211,922 | $78,724 | 6.4% | $34.79 | 0.0% | COM | 687604108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,445,813 | $78,392 | 6.4% | $16.55 | -1.2% | COM | 92790C104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,700,691 | $73,945 | 6.0% | $15.37 | +81.2% | COM | 252828108 |
| COGT | COGENT BIOSCIENCES INC | 6,225,641 | $67,237 | 5.5% | $8.53 | +14.2% | COM | 19240Q201 |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | 3,103,448 | $43,231 | 3.5% | $14.27 | 0.0% | COM | 23954D109 |
| — | ASTRIA THERAPEUTICS INC | 3,554,129 | $39,131 | 3.2% | $9.99 | — | COM | 04635X102 |
| BCAX | BICARA THERAPEUTICS INC | 1,284,169 | $32,708 | 2.7% | $25.50 | 0.0% | COM | 055477103 |
| ZBIO | ZENAS BIOPHARMA INC | 1,892,806 | $32,026 | 2.6% | $17.98 | 0.0% | COM | 98937L105 |
| BCYC | BICYCLE THERAPEUTICS PLC | 123,538 | $2,796 | 0.2% | $20.24 | — | SPONSORED ADS | 088786108 |